Trident Lifeline Ltd (TLL) fair value: what the stock is really worth
As of Nov 19, 2026: fair value (intrinsic value) of Trident Lifeline Ltd stock ₹271, price ₹410, that is 33.9% below the price, quality 39 out of 100. Rating: overvalued. Calculated from audited financials with 14 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Trident Lifeline Ltd
TLL · BSEExpensive (fair value 34% below the price) and weak company, but rising price: meets 1 of 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 17, 2026.
How to read this chart
49‑month range ₹108.15 – ₹434.50 · fair‑value band ₹202.64 – ₹353.16 · the ₹410.00 price screens above the ₹271.05 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 17, 2026.
Every Wednesday you see whether Trident Lifeline is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Trident Lifeline Limited, a pharmaceutical company, engages in the manufacture and marketing of finished dosages in India, Ghana, Kenya, Peru, Cameroon, Venezuela, and internationally.
Show moreShow less
It offers pharmaceutical products in the form of tablets, capsules, liquid orals, external preparations, gel, mouthwash, and lotion; and nutraceutical tablets, capsules, liquids, sachets, oral sprays, and effervescent tablets, as well as ice gels, pastes, solutions, suspension, syrup, cream, drypowders, and toothpastes.
The company was incorporated in 2014 and is based in Surat, India.
Stock analysis
Trident Lifeline Ltd (TLL) currently trades at ₹410.00, while our model-based Fair Value estimate is ₹271.05, 34% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹738.39 per share, and 4 of the 14 models we run sit above the ₹410.00 price.
Bear case: the Economic Profit group reads lowest at ₹78.89, and 10 of the 14 models stay below the price. Data coverage for this calculation is medium.
Scenario range: ₹202.64 (bear) to ₹353.16 (bull), the price of ₹410.00 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 39/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Trident Lifeline Ltd reported revenue of ₹1.3B in FY2026 versus ₹218M in FY2022, a compound +56.0%/yr. Reported net income was ₹190M in FY2026, compounding +48.2%/yr from FY2022.
Key figures
Market cap ₹4.9B (≈ $52.3M) Micro · P/E ratio 22.9 · P/S ratio 3.52 · EPS (TTM) ₹17.93 · Net margin 15.1% · Return on equity 21.8% · Return on assets (EBIT) 10.7% (5-year average) · Operating margin 20.4%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 64 out of 100 (low confidence).
What moves the price
The share trades about 6% below its 52-week high and 72% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 20% fair-value upside, at −34%, TLL screens richer than that median.
Fair Value models
All 14 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
TLL screens overvalued: fair value 34% below the price. Compare with JD Health International Inc →
Compare Trident Lifeline Ltd with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Pharmaceutical Retailers · 55 stocks
Valuation Multiplesvs Pharmaceutical Retailers median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on assets by industry
- Fair value gap by industry
- PEG screener for stocks with fair value
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Pharmaceutical Retailers stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| JD Health International Inc 6618 | HK$32.42 | HK$75.43 | +133% | vs TLL |
| Yifeng Pharmacy Chain Co 603939 | ¥26.50 | ¥40.59 | +53% | vs TLL |
| Yixintang Pharmaceutical Group 002727 | ¥13.10 | ¥18.92 | +44% | vs TLL |
| DaShenLin Pharmaceutical Group 603233 | ¥20.76 | ¥25.52 | +23% | vs TLL |
| Nahdi Medical Company 4164 | 94.05 SAR | 113.21 SAR | +20% | vs TLL |
| Anhui Huaren Health Pharmaceutical Co 301408 | ¥12.08 | ¥13.85 | +15% | vs TLL |
| LBX Pharmacy Chain Joint Stock Company 603883 | ¥14.63 | ¥16.40 | +12% | vs TLL |
| DocMorris AG DOCM | CHF 18.80 | CHF 15.17 | −19% | vs TLL |
| ShuYu Civilian Pharmacy Corp 301017 | ¥10.76 | ¥5.91 | −45% | vs TLL |
| Apotea AB APOTEA | kr 101.50 | kr 39.50 | −61% | vs TLL |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Trident Lifeline Ltd (TLL) overvalued or undervalued?
What is the fair value of TLL?
What is the quality score of TLL?
What is the price target for Trident Lifeline Ltd (TLL)?
What is the Trident Lifeline Ltd stock forecast for 2026?
What is the revenue of Trident Lifeline Ltd (TLL)?
What is the intrinsic value of Trident Lifeline Ltd (TLL)?
Is Trident Lifeline Ltd stock overvalued or undervalued in 2026?
Is fair value the same as the market price of TLL?
How much is Trident Lifeline Ltd worth?
What do the bullish and bearish scenarios say about TLL?
What is the P/E ratio of TLL?
How solid is the balance sheet of Trident Lifeline Ltd (TLL)?
How far is TLL from its 52-week high?
Which stocks are comparable to Trident Lifeline Ltd?
Is Trident Lifeline Ltd stock attractive at the current price?
How is the fair value of TLL calculated?
Is it still worth investing in stocks now?
What is the share price of Trident Lifeline Ltd (TLL)?
What should I pay attention to with Trident Lifeline Ltd right now?
Key figures of Trident Lifeline Ltd
How large is the market capitalisation of Trident Lifeline Ltd (TLL)?
What is the P/S ratio of Trident Lifeline Ltd (TLL)?
What are the earnings per share of Trident Lifeline Ltd (TLL)?
What is the net margin of Trident Lifeline Ltd (TLL)?
What is the return on equity of Trident Lifeline Ltd (TLL)?
What is the EBIT return on assets of Trident Lifeline Ltd (TLL)?
What is the operating margin of Trident Lifeline Ltd (TLL)?
How fast is revenue growing at Trident Lifeline Ltd (TLL)?
How fast are earnings growing at Trident Lifeline Ltd (TLL)?
How much free cash flow does Trident Lifeline Ltd (TLL) generate?
How much net debt does Trident Lifeline Ltd (TLL) carry?
Watch Trident Lifeline Ltd in the live analysis
One click puts Trident Lifeline Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.